Drug intelligence / Profile preview

DFO Nano Gel

Development stage
Unknown
Lead developer
Ozone Pharmaceuticals
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

DFO Nano Gel is a topical fixed-dose combination gel developed and manufactured by Ozone Pharmaceuticals for the localized relief of pain, swelling, and inflammation associated with musculoskeletal disorders, joint pain, osteoarthritis, sprains, and strains. The formulation combines four active ingredients: diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) to reduce prostaglandin synthesis; methyl salicylate and menthol, which act as counterirritants and transient receptor potential (TRP) channel agonists (targeting TRPA1, TRPV1, and TRPM8) to produce cooling and warming sensations that distract from deeper pain; and linseed oil (oleum lini), which provides mild anti-inflammatory properties and acts as a penetration enhancer to facilitate deep tissue absorption of the active components.

Brand names
DFO Nano GelDfo GelEndpin Liniment OilKupin GelQupen GelVovedic Plus Gel
Other names
Diclofenac + Oleum liniDiclofenac + Oleum lini + Menthol + Methyl Salicylatediclofenac + linseed oil + menthol + methyl salicylatediclofenac diethylamine + linseed oil + menthol + methyl salicylatediclofenac diethylammonium + linseed oil + menthol + methyl salicylate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on DFO Nano Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DFO Nano Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call